Long-term outcomes in children with absent pulmonary valve syndrome: it is not just fixing the heart

2021 ◽  
pp. archdischild-2020-320219
Author(s):  
Katalin Torok ◽  
Elizabeth Brettle ◽  
Tarak Desai ◽  
Paul Miller ◽  
Natasha Khan ◽  
...  

Objective Absent pulmonary valve syndrome (APV) is a rare condition usually associated with tetralogy of Fallot (TOF). Some infants develop respiratory failure from bronchial compression and the long-term neurodevelopmental outcome is unknown. We aimed to investigate the outcomes of APV and the need for long-term ventilation (LTV). Design, patients and setting Retrospective single-centre review of patients diagnosed with APV between 2007 and 2017. Outcome measures Survival, neurological disability and postoperative LTV (≥3 months of non-invasive or invasive respiratory support). Results Thirty patients were identified, 22 (73%) of whom were prenatally diagnosed. Pregnancy was discontinued in one patient, while in utero death occurred in three. One was lost to follow-up. Of the remaining 25 liveborn, 21 had the classic TOF/APV. One baby died immediately after birth, while two patients had palliative care due to severe airway compression and inability to wean ventilation support. Surgical repair was performed in 21 of the 25 (84%) liveborn, with one awaiting surgery. Of those undergoing surgery, two patients died: one during surgery and the other due to severe airway malacia 5 months postsurgery. In the surgical group survival from birth at 1 and 5 years was 89% (95% CI 75% to 100%). Six (30%) patients required LTV postoperatively; all had surgery within the first 6 months of life. Learning and/or other physical difficulties were evident in 63%. Conclusions Majority of patients with APV are diagnosed antenatally. A third of those operated required LTV and over half had learning and/or other physical difficulties. Prospective studies are needed to identify prenatal factors that predict postnatal outcomes so parents can be counselled appropriately.

2014 ◽  
Vol 97 (5) ◽  
pp. 1671-1677 ◽  
Author(s):  
Matthew S. Yong ◽  
Deane Yim ◽  
Christian P. Brizard ◽  
Terry Robertson ◽  
Andrew Bullock ◽  
...  

Author(s):  
Elizabeth Brettle ◽  
Katalin Torok ◽  
Tarak Desai ◽  
Isobel Brookes ◽  
Priti Kenia ◽  
...  

2006 ◽  
Vol 29 (5) ◽  
pp. 682-687 ◽  
Author(s):  
Martin A. Nørgaard ◽  
Nelson Alphonso ◽  
Andrew E. Newcomb ◽  
Christian P. Brizard ◽  
Andrew D. Cochrane

2008 ◽  
Vol 18 (2) ◽  
pp. 141-146 ◽  
Author(s):  
Ji-Hyuk Yang ◽  
Tae-Gook Jun ◽  
Pyo W. Park ◽  
Kiick Sung ◽  
Wook S. Kim ◽  
...  

AbstractObjectivesTo maintain pulmonary valvar function subsequent to repair of tetralogy of Fallot, we have inserted a homograft monocusp when a transjunctional patch was required. In this study, we have evaluated the mid- to long-term outcomes, aiming to determine the durability of the homograft.MethodsAmong 218 repairs performed for tetralogy of Fallot between July, 1996, and June, 2005, we inserted homograft monocusps in 54 patients, 4 of whom had associated absent pulmonary valve syndrome, 3 had pulmonary valvar atresia, and 1 had an atrioventricular septal defect with common atrioventricular junction. The median body weight at surgery was 7.8 kilograms, with a range from 3.9 to 42 kilograms. The function of the monocusp valve was assessed by regular echocardiography, using the Kaplan-Meier method and the Cox regression model for statistical analyses.ResultsThere were 2 early deaths (3.7%), associated with respiratory infection. No late deaths were observed during the follow-up, which ranged from 0.3 to 120 months, with a median of 64.3 months. Freedom from valvar dysfunction was 67.2 ± 6.7% at 1 year, 37.1 ± 7.3% at 3 years, 23.8 ± 6.7% at 5 years, and 21.2 ± 6.4% at 7 years. We needed to replace the valve in 1 patient during follow-up. We found that ABO blood group incompatibility, stenosis of the pulmonary arteries, and associated absent pulmonary valve syndrome all adversely affected the function of the monocusp.ConclusionOur experiences show that insertion of a homograft monocusp can prevent pulmonary regurgitation in the early period after repair of tetralogy of Fallot, but the effects are limited in duration as degeneration progressed. We still need to determine whether this finding can improve the longer-term function of the right ventricle.


2000 ◽  
Vol 10 (6) ◽  
pp. 618-620 ◽  
Author(s):  
Doff B. McElhinney ◽  
Frank L. Hanley ◽  
Paul Stanger

AbstractDeletions of chromosome 22q11 are common in patients with tetralogy of Fallot, and in those with absent pulmonary valve syndrome. In this report, we describe a pair of siblings with absent pulmonary valve syndrome, neither of whom had deletions of chromosome 22q11. The finding of familial absent pulmonary valve syndrome without deletion of 22q11 in our patients suggests an alternative genetic basis for this rare condition.


1997 ◽  
Vol 12 (3) ◽  
pp. 180-184 ◽  
Author(s):  
Pitambar Shatapathy ◽  
Bhuvnesh Kumar Aggarwal ◽  
S. Ganesh Kamath ◽  
Srinivas Sai

Sign in / Sign up

Export Citation Format

Share Document